Literature DB >> 7567731

Drug treatment of toxoplasmic encephalitis in acquired immunodeficiency syndrome.

P Winstanley1.   

Abstract

Toxoplasma gondii is a ubiquitous parasite, which causes several serious diseases. Until the AIDS pandemic, toxoplasmic encephalitis was largely confined to the pharmacologically immune-suppressed and to cases of congenital transmission. T gondii is now one of the more commonly encountered opportunistic pathogens of advanced AIDS.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7567731      PMCID： PMC2397974          DOI： 10.1136/pgmj.71.837.404

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  5 in total

1.  Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. The California Collaborative Treatment Group.

Authors:  B Dannemann; J A McCutchan; D Israelski; D Antoniskis; C Leport; B Luft; J Nussbaum; N Clumeck; P Morlat; J Chiu
Journal:  Ann Intern Med       Date:  1992-01-01       Impact factor: 25.391

2.  Pyrimethamine concentrations in serum and cerebrospinal fluid during treatment of acute Toxoplasma encephalitis in patients with AIDS.

Authors:  L M Weiss; C Harris; M Berger; H B Tanowitz; M Wittner
Journal:  J Infect Dis       Date:  1988-03       Impact factor: 5.226

3.  The disposition of oral and intramuscular pyrimethamine/sulphadoxine in Kenyan children with high parasitaemia but clinically non-severe falciparum malaria.

Authors:  P A Winstanley; W M Watkins; C R Newton; C Nevill; E Mberu; P A Warn; C M Waruiru; I N Mwangi; D A Warrell; K Marsh
Journal:  Br J Clin Pharmacol       Date:  1992-02       Impact factor: 4.335

4.  Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome.

Authors:  S B Porter; M A Sande
Journal:  N Engl J Med       Date:  1992-12-03       Impact factor: 91.245

Review 5.  Toxoplasmic encephalitis in AIDS.

Authors:  B J Luft; J S Remington
Journal:  Clin Infect Dis       Date:  1992-08       Impact factor: 9.079
  5 in total
  6 in total

1.  Seroprevalence of Toxoplasma IgG Antibodies in HIV Positive Patients in and Around Khammam, Telangana State.

Authors:  Basavaraju Anuradha; Chilupuri Preethi
Journal:  J Clin Diagn Res       Date:  2014-09-20

2.  The morphological analysis of autophagy in primary skeletal muscle cells infected with Toxoplasma gondii.

Authors:  Xênia Macedo Souto; Helene Santos Barbosa; Rubem Figueiredo Sadok Menna-Barreto
Journal:  Parasitol Res       Date:  2016-04-14       Impact factor: 2.289

3.  Serological Assessment of 18 Pathogens and Risk of AIDS-Associated Non-Hodgkin Lymphoma.

Authors:  Gordana Halec; Tim Waterboer; Nicole Brenner; Julia Butt; W David Hardy; Gypsyamber DʼSouza; Steven Wolinsky; Bernard J Macatangay; Michael Pawlita; Roger Detels; Otoniel Martínez-Maza; Shehnaz K Hussain
Journal:  J Acquir Immune Defic Syndr       Date:  2019-03-01       Impact factor: 3.771

4.  Toxoplasmosis in HIV infection: An overview.

Authors:  Anuradha Basavaraju
Journal:  Trop Parasitol       Date:  2016 Jul-Dec

5.  Acquisition of Host Cytosolic Protein by Toxoplasma gondii Bradyzoites.

Authors:  Geetha Kannan; Pariyamon Thaprawat; Tracey L Schultz; Vern B Carruthers
Journal:  mSphere       Date:  2021-01-27       Impact factor: 4.389

6.  Role of Toxoplasma gondii Chloroquine Resistance Transporter in Bradyzoite Viability and Digestive Vacuole Maintenance.

Authors:  Geetha Kannan; Manlio Di Cristina; Aric J Schultz; My-Hang Huynh; Fengrong Wang; Tracey L Schultz; Matteo Lunghi; Isabelle Coppens; Vern B Carruthers
Journal:  mBio       Date:  2019-08-06       Impact factor: 7.867
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.